GRCE Market Cap & Key Metrics
Grace Therapeutics, Inc.
$2.05
+$0.00(+0.25%)
32
Overall
60
Value
10
Tech
26
Quality
Market Cap
$42.91M
Volume
10.05K
52W Range
$1.79 - $5.18
Target Price
$6.00
GRCE market cap is $42.91M. This page lists Grace Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
GRCE Key Metrics
- Market cap
- $42.91M
- EPS estimate, current year
- $-0.80
- EPS growth, 3-year
- +20.91%
- Value score
- 60
- Quality score
- 26
- Technical score
- 10
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| EBITDA | -$9.49M | -$12.76M | -$14.67M | -$51.85M | -$15.34M |
| EPS | $-0.47 | $-0.79 | $-1.35 | $-0.95 | $-0.27 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRCE | $2.05 | +0.2% | 10.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Grace Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW